01/07/2019 |
 |
Jeremy Davis, M.D., Surgical Oncologist at the Center for Cancer Research in the National Cancer Institute discusses a phase II clinical trial for patients with Hereditary Diffuse Gastric Cancer Syndrome. ccr.cancer.gov/surgical- ccr.cancer.gov/clinical-trials |
lunes, 7 de enero de 2019
Clinical Trial Conversation: Hereditary Diffuse Gastric Cancer
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario